08 January 2021 3 Min Read
EU secures nearly half Pfizer’s 2021 global vaccine output
The deal with Pfizer and BioNTech allows for 300-million additional doses, likely requiring an expansion of the firms’ production capacity
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In